Each uncoated tablet contains : |
|
|
Diclofenac Sodium |
I.P. |
50 mg |
Paracetamol |
I.P. |
325 mg |
Excipients |
|
q.s. |
127 |
Tablets |
Amlodipine Besylate and Metoprolol Succinate (ER)Tablets |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Amlodipine Besylate (Eq. to Amlodipine) |
I.P. |
5 mg |
Metoprolol Succinate (eq. to Metoprolol Tartrate, Extended Released) |
I.P. |
47.5 mg (50 mg eq.) |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
128 |
Tablets |
Amlodipine Besilate and Atenolol Tablets I.P. |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Amlodipine Besilate (eq. to Amlodipine) |
I.P. |
5 mg |
Atenolol |
I.P. |
50 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
129 |
Tablets |
Amlodipine Besilate Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Amlodipine Besilate (eq. to Amlodipine) |
I.P. |
5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
130 |
Tablets |
Metformin Hydrochloride Sustained Released Tablets I.P. |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Metformin Hydrochloride (sustained released) |
I.P. |
500 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
131 |
Tablets |
Losartan Potassium and Hydrochlorothiazide Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Losartan Potassium |
I.P. |
50 mg |
Hydrochlorothiazide |
I.P. |
12.5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
132 |
Tablets |
Losartan Potassium and Amlodipine Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Losartan Potassium |
I.P. |
50 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
133 |
Tablets |
Losartan Potassium Tablets I.P. 50 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Losartan Potassium |
I.P. |
50 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
134 |
Tablets |
Linezolid Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Linezolid |
I.P. |
600 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
135 |
Tablets |
Olmesartan Medoxomil and Amlodipine Tablets |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Olmesartan Medoxomil |
I.P. |
40 mg |
Amlodipine Besylate (eq. to Amlodipine) |
I.P. |
5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
136 |
Tablets |
Olmesartan Medoxomil 20 mg and Hydrochlorothiazide 12.5 mg Tablets I.P |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Olmesartan Medoxomil |
I.P. |
20 mg |
Hydrochlorothiazide |
I.P. |
12.5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
137 |
Tablets |
Olmesartan Medoxomil Tablets I.P. 40 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Olmesartan Medoxomil |
I.P. |
40 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
138 |
Tablets |
Olmesartan Medoxomil Tablets I.P. 20 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Olmesartan Medoxomil |
I.P. |
20 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
139 |
Tablets |
Loratadine Tablets I.P. |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Loratadine |
I.P. |
10 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
140 |
Tablets |
Citicoline Tablets I.P 500 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Citicoline Sodium (eq. to Citicoline) |
I.P. |
500 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
141 |
Tablets |
Hydroxyzine Tablets I.P. 25 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Hydroxyzine Hydrochloride |
I.P. |
25 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
142 |
Tablets |
Hydroxyzine Tablets I.P. 10 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Hydroxyzine Hydrochloride |
I.P. |
10 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
143 |
Tablets |
Voglibose Tablets I.P. 0.3 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Voglibose |
I.P. |
0.3 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
144 |
Tablets |
Voglibose Tablets I.P. 0.2 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Voglibose |
I.P. |
0.2 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
145 |
Tablets |
Febuxostat Tablets 80 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Febuxostat |
|
80 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
146 |
Tablets |
Febuxostat Tablets 40 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Febuxostat |
|
40 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
147 |
Tablets |
Serratiopeptidase Tablets I.P. 10 mg |
Composition |
Standard |
Quantity |
Each enteric coated tablet contains : |
|
|
Serratiopeptidase (as enteric coated granules eq. to enzymatic activity 20,000 units) |
I.P. |
10 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
148 |
Tablets |
Paracetamol Tablets I.P. 650 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Paracetamol |
I.P. |
650 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
149 |
Tablets |
Betahistine Hydrochloride Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Betahistine Hydrochloride |
I.P. |
8 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
150 |
Tablets |
Betahistine Hydrochloride Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Betahistine Hydrochloride |
I.P. |
16 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
151 |
Tablets |
Levocetirizine Tablets I.P. 5 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Levocetirizine Hydrochloride |
I.P. |
5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
152 |
Tablets |
Cetirizine Hydrochloride Tablets I.P. 10 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Cetirizine Hydrochloride |
I.P. |
10 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
153 |
Tablets |
Pantoprazole Gastro-resistant Tablets I.P. 40 mg |
Composition |
Standard |
Quantity |
Each enteric-coated tablet contains : |
|
|
Pantoprazole Sodium eq. to Pantoprazole |
I.P. |
40 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
154 |
Tablets |
Divalproex Extended Release Tablets I.P 1000mg |
Composition |
Standard |
Quantity |
Each film-coated extended-release tablet contains : |
|
|
Divalproex Sodium eq. to Valproic Acid |
I.P. |
1000 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
155 |
Tablets |
Divalproex Extended Release Tablets I.P 500mg |
Composition |
Standard |
Quantity |
Each film-coated extended-release tablet contains : |
|
|
Divalproex Sodium eq. to Valproic Acid |
I.P. |
500 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
156 |
Tablets |
Divalproex Extended Release Tablets I.P 250mg |
Composition |
Standard |
Quantity |
Each film-coated extended-release tablet contains : |
|
|
Divalproex Sodium eq. to Valproic Acid |
I.P. |
250 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
157 |
Tablets |
Telmisartan, Amlodipine and Hydrochlorothiazide Tablets |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Telmisartan |
I.P. |
40 mg |
Amlodipine Besylate eq. to Amlodipine |
I.P. |
5 mg |
Hydrochlorothiazide |
I.P. |
12.5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
158 |
Tablets |
Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg Tablets I.P |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Telmisartan |
I.P. |
80 mg |
Hydrochlorothiazide |
I.P. |
12.5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
159 |
Tablets |
Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets I.P. |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Telmisartan |
I.P. |
40 mg |
Hydrochlorothiazide |
I.P. |
12.5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
160 |
Tablets |
Telmisartan Tablets I.P. 80 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Telmisartan |
I.P. |
80 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
161 |
Tablets |
Telmisartan Tablets I.P. 40 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Telmisartan |
I.P. |
40 mg |
Excipients |
q.s. |
|
Approved Colour used |
|
|
|
162 |
Tablets |
Telmisartan Tablets I.P. 20 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Telmisartan |
I.P. |
20 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
163 |
Tablets |
Duloxetine Hydrochloride Tablets 30 mg |
Composition |
Standard |
Quantity |
Each enteric-coated tablet contains : |
|
|
Duloxetine Hydrochloride eq. to Duloxetine |
I.P. |
30 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
164 |
Tablets |
Duloxetine Hydrochloride Tablets 20mg |
Composition |
Standard |
Quantity |
Each enteric-coated tablet contains : |
|
|
Duloxetine Hydrochloride eq. to Duloxetine |
I.P. |
20 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
165 |
Tablets |
Rosuvastatin Calcium and Fenofibrate Tablets |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Rosuvastatin Calcium eq. to Rosuvastatin |
I.P. |
10 mg |
Fenofibrate |
I.P. |
160 mg |
Excipients |
|
q.s. |
Colour |
|
|
|
166 |
Tablets |
Rosuvastatin Calcium Tablets I.P. 20 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Rosuvastatin Calcium eq. to Rosuvastatin |
I.P. |
20 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
167 |
Tablets |
Rosuvastatin Calcium Tablets I.P. 10 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Rosuvastatin Calcium eq. to Rosuvastatin |
I.P. |
10 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
168 |
Tablets |
Rosuvastatin Calcium Tablets I.P. 5 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Rosuvastatin Calcium eq. to Rosuvastatin |
I.P. |
5 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
169 |
Tablets |
Methylprednisolone Tablets I.P. 16 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Methylprednisolone |
I.P. |
16 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
170 |
Tablets |
Methylprednisolone Tablets 8 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Methylprednisolone |
I.P. |
8 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
171 |
Tablets |
Methylprednisolone Tablets I.P. 4 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Methylprednisolone |
I.P. |
4 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
172 |
Tablets |
Atenolol Tablets I.P. 100 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Atenolol |
I.P. |
100 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
173 |
Tablets |
Atenolol Tablets I.P. 50 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Atenolol |
I.P. |
50 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
174 |
Tablets |
Atorvastatin Calcium and Fenofibrate Tablets |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Atorvastatin Calcium eq. to Atorvastatin |
I.P. |
10 mg |
Fenofibrate |
I.P. |
160 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
175 |
Tablets |
Atorvastatin Tablets I.P. 40 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Atorvastatin Calcium eq. to Atorvastatin |
I.P. |
40 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
176 |
Tablets |
Atorvastatin Tablets I.P. 20 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Atorvastatin Calcium eq. to Atorvastatin |
I.P. |
20 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
177 |
Tablets |
Atorvastatin Tablets I.P. 10 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Atorvastatin Calcium eq. to Atorvastatin |
I.P. |
10 mg |
Excipients |
|
q.s. |
Approved Colour used |
|
|
|
178 |
Tablets |
Fexofenadine and Montelukast Tablets |
Composition |
Standard |
Quantity |
Each chewable film-coated tablet contains : |
|
|
Fexofenadine Hydrochloride |
I.P. |
120 mg |
Montelukast Sodium eq. to Montelukast |
I.P. |
10 mg |
Excipients |
q.s. |
|
Approved Colour used |
|
|
|
179 |
Tablets |
Fexofenadine Hydrochloride Tablets I.P. 180 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Fexofenadine Hydrochloride |
I.P. |
180 mg |
Excipients |
q.s. |
|
Approved Colour used |
|
|
|
180 |
Tablets |
Fexofenadine Hydrochloride Tablets I.P. 120 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Fexofenadine Hydrochloride |
I.P. |
120 mg |
Excipients |
q.s. |
|
Approved Colour used |
|
|
|
181 |
Tablets |
Escitalopram Tablets I.P 20 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Escitalopram Oxalate eq. to Escitalopram |
I.P. |
20 mg |
Excipients |
q.s. |
|
Approved Colour used |
|
|
|
182 |
Tablets |
Escitalopram Tablets I.P 10 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Escitalopram Oxalate eq. to Escitalopram |
I.P. |
10 mg |
Excipients |
q.s. |
|
Approved Colour used |
|
|
|
183 |
Tablets |
Escitalopram Tablets I.P 5 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Escitalopram Oxalate (eq. to Escitalopram) |
I.P. |
5 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
184 |
Tablets |
Etoricoxib Tablets I.P 120 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Etoricoxib |
I.P. |
120 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
185 |
Tablets |
Etoricoxib Tablets I.P 90 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Etoricoxib |
I.P. |
90 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
186 |
Tablets |
Etoricoxib Tablets I.P 60 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Etoricoxib |
I.P. |
60 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
187 |
Tablets |
Ondansetron Orally Disintegrating Tablets I.P. 8 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Ondansetron Hydrochloride (eq. to Ondansetron) |
I.P. |
8 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
188 |
Tablets |
Ondansetron Orally Disintegrating Tablets I.P. 4 mg |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Ondansetron Hydrochloride (eq. to Ondansetron) |
I.P. |
4 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
189 |
Tablets |
Sildenafil Citrate Tablets I.P. 100 mg |
Composition |
Standard |
Quantity |
Each film-coated tablet contains : |
|
|
Sildenafil Citrate (eq. to Sildenafil) |
I.P. |
100 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
190 |
Tablets |
Paracetamol and Nimesulide Tablets (Not to be used for children below 12 years of age) |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Paracetamol |
I.P. |
325 mg |
Nimesulide |
B.P. |
100 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
191 |
Tablets |
Roxithromycin Tablets I.P. 150 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Roxithromycin |
I.P. |
150 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
192 |
Tablets |
Deflazacort Tablets |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Deflazacort |
— |
30 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
193 |
Tablets |
Deflazacort Tablets |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Deflazacort |
— |
6 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
194 |
Tablets |
Rabeprazole Gastro-resistant Tablets I.P. 20mg |
Composition |
Standard |
Quantity |
Each enteric coated tablet contains : |
|
|
Rabeprazole Sodium |
I.P. |
20 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
195 |
Tablets |
Ofloxacin & Ornidazole Tablets I.P |
Composition |
Standard |
Quantity |
Each film coated tablet contains : |
|
|
Ofloxacin |
I.P. |
200 mg |
Ornidazole |
I.P. |
500 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
196 |
Tablets |
Levofloxacin Tablets I.P. 750 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Levofloxacin Hemihydrate (eq. to Levofloxacin) |
I.P. |
750 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
197 |
Tablets |
Levofloxacin Tablets I.P. 500 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Levofloxacin Hemihydrate (eq. to Levofloxacin) |
I.P. |
500 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
198 |
Tablets |
Levofloxacin Tablets I.P. 250 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Levofloxacin Hemihydrate (eq. to Levofloxacin) |
I.P. |
250 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
199 |
Tablets |
Pregabalin, Nortriptyline & Mecobalamin Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Pregabalin |
I.P. |
75 mg |
Nortriptyline Hydrochloride (Eq. to Nortriptyline) |
I.P. |
10 mg |
Mecobalamin |
I.P. |
1500 mcg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
200 |
Tablets |
Azithromycin & Lactic Acid Bacillus Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Azithromycin Dihydrate (eq. to Azithromycin anhydrous) |
I.P. |
500 mg |
Lactic Acid Bacillus |
— |
60 Million Spores |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
201 |
Tablets |
Ferrous Ascorbate, Cyanocobalamin, Folic Acid, Zinc Sulphate Monohydrate Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Ferrous Ascorbate |
— |
100 mg |
Cyanocobalamin |
I.P. |
15 mcg |
Folic Acid |
I.P. |
1.5 mg |
Zinc Sulphate Monohydrate (eq. to Elemental Zinc) |
I.P. |
22.5 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
202 |
Tablets |
Ofloxacin Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Ofloxacin |
I.P. |
200 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
203 |
Tablets |
Pregabalin (SR) and Methylcobalamin Tablets |
Composition |
Standard |
Quantity |
Each uncoated tablet contains: |
|
|
Pregabalin (Sustained Release) |
I.P. |
75 mg |
Methylcobalamin |
I.P. |
1500 mcg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
204 |
Tablets |
Calcium Citrate, Zinc,Vitamin D3 and Magnesium Tablets |
Composition |
Standard |
Quantity |
Each uncoated tablet contains: |
|
|
Calcium Citrate |
USP |
1000 mg |
Zinc Sulphate Monohydrate eq. to Elemental Zinc |
I.P. |
4 mg |
Vitamin D3 |
I.P. |
200 IU |
Magnesium Hydroxide eq. to Elemental Magnesium |
I.P. |
100 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
205 |
Tablets |
Gabapentin and Methylcobalamin Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Gabapentin |
I.P. |
300 mg |
Methylcobalamin |
I.P. |
500 mcg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
206 |
Tablets |
Azithromycin Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Azithromycin Dihydrate (eq. to Azithromycin Anhydrous) |
I.P. |
500 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
207 |
Tablets |
Azithromycin Tablets I.P. |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Azithromycin Dihydrate (eq. to Azithromycin Anhydrous) |
I.P. |
250 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
208 |
Tablets |
Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Ferrous Ascorbate (eq. to Elemental Iron) |
— |
100 mg |
Folic Acid |
I.P. |
1.5 mg |
Zinc Sulphate Monohydrate (eq. to Elemental Zinc) |
I.P. |
22.5 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
209 |
Tablets |
Aceclofenac, Paracetamol and Thiocolchicoside Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Aceclofenac |
I.P. |
100 mg |
Paracetamol |
I.P. |
325 mg |
Thiocolchicoside |
I.P. |
4 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
210 |
Tablets |
Ursodeoxycholic Acid Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Ursodeoxycholic Acid |
I.P. |
300 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
211 |
Tablets |
Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Aceclofenac |
I.P. |
100 mg |
Paracetamol |
I.P. |
325 mg |
Serratiopeptidase
(eq. to enzymatic activity 20,000 units)
(as enteric coated granules)
|
I.P. |
10 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
212 |
Tablets |
Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Aceclofenac |
I.P. |
100 mg |
Paracetamol |
I.P. |
325 mg |
Serratiopeptidase
(eq. to enzymatic activity 30,000 units)
(as enteric coated granules)
|
I.P. |
15 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
213 |
Tablets |
Aceclofenac, Paracetamol and Chlorzoxazone Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Aceclofenac |
I.P. |
100 mg |
Paracetamol |
I.P. |
325 mg |
Chlorzoxazone |
U.S.P. |
250 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
214 |
Tablets |
Aceclofenac and Paracetamol Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Aceclofenac |
I.P. |
100 mg |
Paracetamol |
I.P. |
325 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
215 |
Tablets |
Aceclofenac and Thiocolchicoside Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Aceclofenac |
I.P. |
100 mg |
Thiocolchicoside |
I.P. |
4 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
216 |
Tablets |
Telmisartan and Amlodipine Besilate Tablets I.P |
Composition |
Standard |
Quantity |
Each uncoated tablet contains: |
|
|
Telmisartan |
I.P. |
40 mg |
Amlodipine Besilate eq. to Amlodipine |
I.P. |
5 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
217 |
Tablets |
Etoricoxib and Thiocolchicoside Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Etoricoxib |
I.P. |
60 mg |
Thiocolchicoside |
I.P. |
4 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
218 |
Tablets |
Montelukast and Levocetirizine Tablets I.P |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Montelukast Sodium eq. to Montelukast |
I.P. |
10 mg |
Levocetirizine Hydrochloride |
I.P. |
5 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
219 |
Tablets |
Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Pyridoxine HCl and Vitamin D3 Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Alpha Lipoic Acid |
USP |
100 mg |
Folic Acid |
I.P |
1.5 mg |
Methylcobalamin |
I.P |
1500 mcg |
Pyridoxine Hydrochloride |
I.P |
3 mg |
Vitamin D3 |
I.P |
1000 IU |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
220 |
Tablets |
Paracetamol, Phenylephrine HCl, Diphenhydramine HCl and Caffeine Tablets |
Composition |
Standard |
Quantity |
Each chewable film-coated tablet contains : |
|
|
Fexofenadine Hydrochloride |
I.P. |
120 mg |
Montelukast Sodium eq. to Montelukast |
I.P. |
10 mg |
Excipients |
q.s. |
|
Approved Colour used |
|
|
|
221 |
Tablets |
Levetiracetam Tablets I.P 500 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Levetiracetam |
I.P |
500 mg |
Excipients |
— |
q.s. |
Approved colour used |
— |
— |
|
222 |
Tablets |
Ketoconazole Tablets I.P 200mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Ketoconazole |
I.P |
200 mg |
Excipients |
— |
q.s. |
Approved colour used |
— |
— |
|
223 |
Tablets |
Aceclofenac & Drotaverine HCl Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Aceclofenac |
I.P |
100 mg |
Drotaverine Hydrochloride |
I.P |
80 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
224 |
Tablets |
Etodolac and Paracetamol Tablets |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Etodolac |
I.P |
400 mg |
Paracetamol |
I.P |
325 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
225 |
Tablets |
Amisulpiride Tablets I.P 100 mg |
Composition |
Standard |
Quantity |
Each film coated tablet contains: |
|
|
Amisulpride |
I.P |
100 mg |
Excipients |
— |
q.s. |
Approved colour used |
— |
— |
|
226 |
Tablets |
Etodolac ER Tablets 400MG |
Composition |
Standard |
Quantity |
Each film coated extended release tablet contains: |
|
|
Etodolac |
I.P |
400 mg |
Excipients |
— |
q.s. |
Approved Colour used |
— |
— |
|
227 |
Tablets |
Nimesulide Tablets (Not to be used for children below 12 years of age) |
Composition |
Standard |
Quantity |
Each uncoated tablet contains : |
|
|
Nimesulide |
B.P. |
100 mg |
Excipients |
q.s. |
|
Approved Colour used |
|
|
|